Research team identifies new class of antibiotics to fight drug resistance

According to the World Health Organization, antibiotic resistant is one of the biggest threats to global health today and a significant contributor to longer hospital stays, higher medical costs and increased mortality.

Know more and share more, please visit: Medicinal Chemistry Conferences

The Organizing Committee of Medicinal Chemistry Conferences is inviting you to attend Euro Medicinal Chemistry Congress 2019 in April 01 - 02 | Prague, Czech Republic. The topic of the current year's gathering is "Deliberate the challenges in the New era of Optimizing Medicinal Chemistry & Drug Design Research Reforms" which will give a worldwide stage to talk of present and future of Medicinal Chemistry and research. 

Researchers from the University of Illinois at Chicago and Nosopharm, a biotechnology company based in Lyon, France, are part of an international team reporting on the discovery of a new class of antibiotics.

The antibiotic, first identified by Nosopharm, is unique and promising on two fronts: its unconventional source and its distinct way of killing bacteria, both of which suggest the compound may be effective at treating drug-resistant or hard-to-treat bacterial infections.

Called odilorhabdins, or ODLs, the antibiotics are produced by symbiotic bacteria found in soil-dwelling nematode worms that colonize insects for food. The bacteria help to kill the insect and, importantly, secrete the antibiotic to keep competing bacteria away. Until now, these nematode-associated bacteria and the antibiotics they make have been largely understudied.

Researchers create candidate drugs with potential to curb smoking

Washington State University researchers have created more than a dozen candidate drugs with the potential to curb smokers' desire for nicotine by slowing how it is broken down in the body. The researchers hope the substances can help people reduce their consumption of tobacco, if not quit altogether.

The discovery, published in the Journal of Medicinal Chemistry, targets a liver enzyme, called CYP2A6, which metabolizes nicotine. Canadian researchers in the mid-90s found that people who have fewer copies of a gene for the enzyme tend to smoke less and are less likely to be addicted to smoking.

"If you inhibit CYP2A6, it shouldn't bother your overall health," said Lazarus. "If we could specifically target this enzyme, people should be fine, and it will possibly help them stop smoking or at least decrease their amount of smoking."

So far, the researchers have tested their candidate drugs to make sure they don't disrupt other major enzymes that help the body metabolize other substances. This helped narrow the number of potential drugs down to 18.

Share your research on an international stage. Attend with your research group and avail discount on group participation

Click here, to register: Medicinal Chemistry Conferences

Attend the  Euro Medicinal Chemistry Congress 2019 which is going to be held during April 01 - 02, 2019 at Prague, Czech Republic. The topic of the current year's gathering is "Deliberate the challenges in the New era of Optimizing Medicinal Chemistry & Drug Design Research Reforms" which will give a worldwide stage to talk of present and future of Medicinal Chemistry and research.

Chemist begins new project to develop carbohydrate mimics to assist cancer therapies

Dr. Robert Britton, a GlycoNet network investigator and professor at Simon Fraser University has embarked on an ambitious project to develop carbohydrate mimics to assist cancer therapies by making them more selective in how they target and kill cancer cells.

Britton's work focuses on the binding of the antibody to the cancer cell which leads to the recruitment of Natural killer cells and results in Antibody-Dependent Cell-mediated Cytotoxicity (ADCC). ADCC is a critical mechanism underlying the clinical efficacy of therapeutic anticancer antibodies. After the cancer cell is terminated, the human body will naturally get rid of it.

Britton explains the goal of his project is to develop fucosylation inhibitors that do not transfer themselves to the antibody.

Share your research at an international stage and meet the world class experts of Pharma both from Academia and Industry

Please visit for more details: Medicinal Chemistry Conferences 

Attend the  Euro Medicinal Chemistry Congress 2019 which is going to be held during April 01 - 02, 2019 at Prague, Czech Republic. The topic of the current year's gathering is "Deliberate the challenges in the New era of Optimizing Medicinal Chemistry & Drug Design Research Reforms" which will give a worldwide stage to talk of present and future of Medicinal Chemistry and research.  

New therapeutic may help drug addicts avoid future drug use

To know more about the current research in medicinal chemistry, attend the Euro Medicinal Chemistry Conference 2019 in April 01 - 02 | Prague, Czech Republic. The topic of the current year's gathering is "Deliberate the challenges in the New era of Optimizing Medicinal Chemistry & Drug Design Research Reforms" which will give a worldwide stage to talk of present and future of Medicinal Chemistry and research.

Submit your abstract to the session: Medicinal Chemistry Conferences

A new therapeutic may help reverse chemical imbalances made to the brain by habitual drug use and could one day help recovering drug addicts avoid future drug use. Researchers from The University of Texas Medical Branch at Galveston developed and tested a treatment on rats and found it effective in reducing the animals' cravings. Their findings are in the Journal of Medicinal Chemistry. UTMB pharmacology and toxicology professors Jia Zhou, Kathryn Cunningham and their colleagues found that the serotonin 2C receptors in drug addicts do not work as well as they should. They designed, synthesized and pharmacologically evaluated a series of small molecule therapeutics designed to restore the weakened signaling. A serotonin 2C receptor.

Scientists find way to boost efficacy of powerful antimalarial drug with anti-cancer medicines

Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

Scientists from the University of Melbourne and the Japanese pharmaceutical company Takeda have discovered that antimalarial drug artemisinin works through a "double whammy" attack on the deadly parasite.

The drug damages proteins in malaria parasites and clogs the parasite's waste disposal system, known as the proteasome.

For more details, please visit: Medicinal Chemistry Conferences

To know more about the current research in medicinal chemistry, attend the Euro Medicinal Chemistry Conference 2019 in April 01 - 02 | Prague, Czech Republic. The topic of the current year's gathering is "Deliberate the challenges in the New era of Optimizing Medicinal Chemistry & Drug Design Research Reforms" which will give a worldwide stage to talk of present and future of Medicinal Chemistry and research. 

The Organizing Committee of Medicinal Chemistry Conferences is inviting you to attend Euro Medicinal Chemistry Congress 2019 in April 01 - 02 | Prague, Czech Republic. The topic of the current year's gathering is "Deliberate the challenges in the New era of Optimizing Medicinal Chemistry & Drug Design Research Reforms" which will give a worldwide stage to talk of present and future of Medicinal Chemistry and research. 

Following are the  major associations related to Medicinal Chemistry. For more details on all the aspects of medicinal chemistry, kindly visit the following link: Medicinal Chemistry Conferences

Major Marketing Associations around the Globe:

• American Association for Clinical Chemistry
• American Chemical Society
• American Institute of Chemists (AIC)
• American Society of Brewing Chemists
• American Society for Mass Spectrometry
• Royal Society of Chemistry (RSC)
• Swedish Chemical Society
• New Swiss Chemical Society
• Syngenta, Hyderabad Area, India
• DCTG, Beijing City, China
• Oceanus Group Ltd, Singapore

Major Marketing Associations in USA:

• American Association for Clinical Chemistry
• American Chemical Society
• American Institute of Chemists (AIC)
• American Society of Brewing Chemists
• American Society for Mass Spectrometry

The Organizing Committee of Medicinal Chemistry Conferences is inviting you to attend Euro Medicinal Chemistry Congress 2019 in April 01 - 02 | Prague, Czech Republic. The topic of the current year's gathering is "Deliberate the challenges in the New era of Optimizing Medicinal Chemistry & Drug Design Research Reforms" which will give a worldwide stage to talk of present and future of Medicinal Chemistry and research. 

For more details, please visit: Medicinal Chemistry Conferences

Benefits to attend Euro Medicinal Chemistry 2019

• Keynote presentation along with interactions to galvanize the scientific community.
• Workshop and symposiums to reach the largest assemblage of participants from the Pharma and Chemistry community.
• A wide track of exhibitors to showcase the new and emerging technologies.
• Platform to global investment community to connect with stakeholders in Pharma and Chemistry sector.
• Young Scientist/ Investigators Award geared towards best budding young research.
• Links to the political marketing resources to expand your business and research network.
• Triumph of Awards, Certificates recognizes your commitment to your profession to encourage the nascent research.

Target Audience:

• Scientists and Researchers
• Directors, CEO’s of Pharmaceutical and Chemical Organizations
• Scholars from Pharmacology, Pharmaceutical, Toxicology backgrounds
• PhD Scholars
• Drug Delivery Technology Manufacturers
• Business Development Managers
• Distributors and Suppliers of Drug Delivery Technologies
• Students, Professors, Researchers, and Faculty of Medicinal Chemistry & Pharmaceutical Sciences from Universities and Medical Colleges
• Researchers from Pharmaceutical Companies, Pharmacy, Pharmacology & Chemical Associations and Societies
• Health professionals
• Pharmacists, Pharmacologists, & Toxicologists
• Business development professionals, Consultants, Pharma, and Toxicology Testing service providers
• Quality control specialists
• Graduates and post graduates in industrial pharmacy
• Medical Devices Manufacturing Companies, CRO
• Data Management Companies.
• Pharmaceutical legislators and regulators
• Drug Delivery Companies & Organizations

The Organizing Committee of Medicinal Chemistry Conferences is inviting you to attend Euro Medicinal Chemistry Congress 2019 in April 01 - 02 | Prague, Czech Republic.

The topic of the current year's gathering is "Deliberate the challenges in the New era of Optimizing Medicinal Chemistry & Drug Design Research Reforms" which will give a worldwide stage to talk of present and future of Medicinal Chemistry and research.

For more details, kindly visit: 

We have a special session on the current trending topic: Medicinal Chemistry Conferences

 Drug Discovery Chemistry:

The discovery of candidate drug targets is challenging, requiring the rapid development of techniques to identify the difference genomic profiling in disease and normal conditions, which will facilitate the understanding of the disease mechanism and the development of potential drugs for disease treatment. Medicinal chemistry has increasingly employed microarrays to identify both key target genes and gene networks that can regulate the effectiveness of drugs. As compared with all the other phases in drug discovery, this stage is complex by the fact that the identified drug target must mollify a variety of standards to permit development to the next step. For example, the target must be selectively present in the pathogen, i.e. medicinal chemistry along with coding genes of drug design target that are preserved across different pathogens and have no human homologs and therefore they represent striking target candidates for new broad-spectrum drugs.

Sub Tracks:

• Fragment-Based Drug Discovery
• Macrocyclics & Constrained Peptides
• Biophysical Approaches for Drug Discovery
• Small Molecules for Cancer Immunotherapy
• Inflammation Inhibitors
• Protein-Protein Interactions
• GPCR-Targeted Drug Design
• Blood-Brain Penetrate Inhibitors
• Kinase Inhibitor Chemistry

Euro Medicinal Chemistry 2019

Euro Medicinal Chemistry 2019 gives a complete 360-degree overview on Medicinal Chemistry along with information on Drug Design, Drug Discovery and Drug Development.

The Organizing Committee of Medicinal Chemistry Conferences is inviting you to attend Euro Medicinal Chemistry Congress 2019 in April 01 - 02 | Prague, Czech Republic.

Submit your abstract now and we have a session for your current research and interest. Click here to submit:

Medicinal Chemistry Conferences

We have a special session on Synthetic Chemistry which covers the following subtopics:

• Addressing Preclinical Toxicity
• Advances in Lead Generation
• Advances in Synthetic Methods
• Alternative Modalities
• Challenges and Opportunities in Fragment Based Drug Discovery
• Chemical Biology in Drug and Target Discovery
• Drug Discovery Tales
• Late Stage Functionalization
• High pressure cryogenic reactions
• Enzymatic reactions
• Cascade addition-cyclization
• Multi-component reactions
• One-pot Syntheses

Synthetic Organic Chemistry is designed to summarize in a single volume method of organic syntheses most dependently employed in the preparation of mono- and di-functional compounds. Synthetic Chemistry is one of the main aspect in medicinal chemistry and is the keytopic discussed at Medicinal Chemistry Conferences. The methods are collected in chapters each of which is &voted to the formation of compounds containing a functional group or related groups.

The Organizing Committee of Medicinal Chemistry Conferences is inviting you to attend Euro Medicinal Chemistry Congress 2019 in April 01 - 02 | Prague, Czech Republic

Visit the website for more details

Medicinal Chemistry Conferences

The 11th International Conference on Medicinal Chemistry and Pharmaceutical Technology will exhibit the products and services from commercial and non-commercial organizations like Drug manufactures, Clinical Trial Sites, Management Consultants, Chemists, Pharmacists, Business delegates and Equipment Manufacturers.

Business and Exhibitor Benefits:

Over 50+ organizations and international pavilions will be exhibiting at the Euro Medicinal Chemistry 2019. Exhibitors will include equipment manufacturers and suppliers, systems providers, finance and investment firms, R&D companies, project developers, trade associations, and government agencies.

In addition to the products and services you will have access to valuable content, including Keynote Presentations, Product Demonstrations and Educational Sessions from today’s industry leaders.

The Euro Medicinal Chemistry 2019 has everything you need, all under one roof, saving you both time and money.   It is the event you cannot afford to miss!

The Organizing Committee of Medicinal Chemistry Conferences is inviting you to attend Euro Medicinal Chemistry Congress 2019 in April 01 - 02 | Prague, Czech Republic. The topic of the current year's gathering is "Deliberate the challenges in the New era of Optimizing Medicinal Chemistry & Drug Design Research Reforms".

Attend the largest networking meet of the year and avail a chance of meeting Pharma Experts all around the world.

Submit your abstract and avail a chance of visiting of Prague. 

Abstract Submission link:

Medicinal Chemistry Conferences

Learning objectives

• Update the participants on the current knowledge including regulatory and scientific thinking in drug development.
• Deal with research requirements, scientific and operational challenges in drug discovery and development
• Exchange experiences and discuss hot topics with experts
• Frame the current issues and create dialogue

Key Features

• Meeting Regulatory expectations
• Devise Strategies
• Explore different statistical approaches to demonstrate with the reference product
• Panel Discussion and Extended Q&A Sessions
• Open forum to discuss your most critical questions around Medicinal Chemistry and its advances.
• Network of National & International Speakers
• Networking with National and International Industry stalwarts who will inspire, educate and engage in all the aspects of Medicinal Chemistry.
• Gain insights and enhance your knowledge on medicinal chemistry along with all the strategies of drug development.
• Provides interaction with the world's well-known CEO's and Directors of the Pharmaceutical companies.

The Organizing Committee of Medicinal Chemistry Conferences is inviting you to attend Euro Medicinal Chemistry Congress 2019 in April 01 - 02 | Prague, Czech Republic

Submit your abstract now and be a panel member of medicinal chemistry conference thereby increasing your networking with world class experts

Abstract submission link:

Medicinal Chemistry Conferences

Medicinal Chemistry Conference 2019 program delves into strategic discussions regarding:

• Market and regulatory developments in the Europe and globally, enlightened by the perspective of drug development experts, industrialists, healthcare professionals and patient’s experiences
• Medicinal Chemistry research and drug discovery practice - what can be learned from the emerging data?
• The impact of Medicinal Chemistry on the competitive landscape of drug candidates
• Developing novel drug molecules and new drug entities
• Innovator Pharmaceutical Products
• Current Challenges and Research trends in the development of drug development
• Medicinal Chemistry: Drug Discovery, Drug Design & Drug Development
• Toxicology and Pharmacology of drugs
• Biopharmaceutical
• Biological Medicines
• Bioequivalence Assessment
• Organic Chemistry and Analytical Chemistry
• Integrating Medicinal Chemistry into Drug Discovery
• Medicinal Chemistry Advances
• QC, R&D, Analysis, and other techniques
• Innovation and Technology for Drug Development
• Intellectual Property Rights
• Novel Drug Delivery Technologies
• Pharmacology and Drug Development
• Pharmaceutical Formulation
• CADD, SBDD, FBDD
• Pharmaceutical Industry